EKSO BIONICS HOLDINGS, INC. - Common Stock (EKSO)

CUSIP: 282644301

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
3,529,556
Total 13F shares
4,039,726
Share change
-1,326,119
Total reported value
$2,464,077
Price per share
$0.61
Number of holders
32
Value change
-$822,166
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 282644301?
CUSIP 282644301 identifies EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13F
Company
61%
2,167,000
$2,513,720 30 Sep 2024
13F
Kent Lake PR LLC
13F 13D/G
Company
4.6%
from 13D/G
1,669,700
$1,936,852 30 Sep 2024
VANGUARD GROUP INC
13F
Company
17%
594,427
$689,535 30 Sep 2024
13F
Cresset Asset Management, LLC
13F
Company
15%
515,615
$598,113 30 Sep 2024
13F
Steven Sherman
3/4/5
Executive Chair
class O/S missing
449,153
$447,177 08 Jun 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.7%
167,308
$194,129 30 Sep 2024
13F
Stanley Stern
3/4/5
Director
class O/S missing
167,008
$166,273 04 Dec 2022
Jack Peurach
3/4/5
President & CEO, Director
class O/S missing
146,142
$145,499 31 Aug 2021
Rhonda A. Wallen
3/4/5
Director
class O/S missing
142,288
$141,662 08 Jun 2023
William R. Shaw
3/4/5
Chief Commercial Officer
class O/S missing
96,943
$96,516 17 Feb 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.1%
74,616
$86,555 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
1.6%
54,749
$63,509 30 Sep 2024
13F
John Glenn
3/4/5
Chief Financial Officer
class O/S missing
35,130
$34,975 22 Mar 2022
Lombard Odier SCmA Compagnie
13F
Individual
0.71%
25,000
$29,000 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.7%
24,850
$28,826 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.66%
23,180
$26,889 30 Sep 2024
13F
Atria Wealth Solutions, Inc.
13F
Company
0.36%
12,667
$14,694 30 Sep 2024
13F
XTX Topco Ltd
13F
Company
0.31%
11,105
$12,882 30 Sep 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.09%
3,084
$3,575 30 Sep 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.03%
1,112
$1,290 30 Sep 2024
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0.01%
458
$531 30 Sep 2024
13F
Tradewinds Capital Management, LLC
13F
Company
0.01%
260
$302 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
246
$285 30 Sep 2024
13F
NewEdge Advisors, LLC
13F
Company
0.01%
200
$232 30 Sep 2024
13F
UBS Group AG
13F
Company
0%
148
$172 30 Sep 2024
13F
Allworth Financial LP
13F
Company
0%
64
$75 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0%
62
$72 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
45
$52 30 Sep 2024
13F
Front Row Advisors LLC
13F
Company
0%
31
$36 30 Sep 2024
13F
WR Wealth Planners, LLC
13F
Company
0%
29
$34 30 Sep 2024
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
26
$30 30 Sep 2024
13F
Eukles Asset Management
13F
Company
0%
13
$15 30 Sep 2024
13F
VOISARD ASSET MANAGEMENT GROUP, INC.
13F
Company
0%
4
$5 30 Sep 2024
13F

Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock (EKSO) as of Q4 2024

As of 31 Dec 2024, EKSO BIONICS HOLDINGS, INC. - Common Stock (EKSO) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,039,726 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, Kent Lake PR LLC, VANGUARD GROUP INC, Cresset Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., Compagnie Lombard Odier SCmA, NORTHERN TRUST CORP, and STATE STREET CORP. This page lists 32 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
27
Q4 2024 holders
32
Holder diff
5
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .